RWS Holdings PLC Employee Benefit Trust Share Purchase (2269Q)

TIDMRWS

RNS Number : 2269Q

RWS Holdings PLC

24 February 2021

For immediate release 24 February 2021

RWS Holdings plc

Employee Benefit Trust Share Purchase

RWS Holdings plc ("RWS" or "the Group"), the world's leading language services and technology group, announces that it has been notified by Ocorian Limited, acting as trustee of the RWS Holdings plc Employee Benefit Trust (the "EBT"), that on 23 February 2021 the EBT purchased in the market a total of 55,896 Ordinary Shares of 1p each at an average price of 637.43p pence per share. The shares will be held in the EBT, a discretionary trust, and are intended to be used to satisfy the exercise of share options by employees. Following this transaction the EBT holds a total of 55,896 shares, representing approximately 0.01% of the RWS's issued share capital.

For further information, please contact:

 
    RWS Holdings plc 
     Andrew Brode, Chairman 
     Richard Thompson, Chief Executive Officer 
     Des Glass, Chief Financial Officer                         01753 480200 
 
      MHP (Financial PR advisor)                                [e-mail] 
      Katie Hunt / Simon Hockridge                             0203 128 8100 
 
      Numis (Nomad & Joint Broker) 
      Stuart Skinner / Kevin Cruickshank / Will Baunton        0207 260 1000 
    Berenberg (Joint Broker) 
     Ben Wright / Toby Flaux / Alix Mecklenburg-Solodkoff      0203 207 7800 
 

About RWS:

RWS is the world's leading language services and technology group. Over the last 60 years, the company has built a reputation for quality, reliability and flexibility with its global team of translators, searchers and technical experts.

RWS's specialist divisions combine the latest technology, proven processes and highly skilled staff to deliver complex services at each stage of the product lifecycle to meet the diverse needs of a global client base spanning Europe, Asia Pacific, and North and South America across a range of sectors including technology, pharmaceutical, medical, chemical, automotive, and telecommunications.

With headquarters in the UK, RWS is publicly listed on AIM, the London Stock Exchange regulated market (RWS.L).

For further information, please visit: www.rws.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHSEIFELEFSEIE

(END) Dow Jones Newswires

February 24, 2021 08:00 ET (13:00 GMT)